1. Home
  2. LHX vs IQV Comparison

LHX vs IQV Comparison

Compare LHX & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L3Harris Technologies Inc.

LHX

L3Harris Technologies Inc.

HOLD

Current Price

$234.74

Market Cap

44.1B

Sector

Industrials

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$258.88

Market Cap

43.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LHX
IQV
Founded
1895
1982
Country
United States
United States
Employees
45000
93000
Industry
Industrial Machinery/Components
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1B
43.1B
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
LHX
IQV
Price
$234.74
$258.88
Analyst Decision
Buy
Strong Buy
Analyst Count
20
22
Target Price
★ $335.33
$290.84
AVG Volume (30 Days)
★ 1.4M
1.3M
Earning Date
10-29-2026
10-27-2026
Dividend Yield
★ 2.10%
N/A
EPS Growth
★ 8.39
4.67
EPS
★ 5.85
1.61
Revenue
$6,182,000,000.00
★ $9,739,000,000.00
Revenue This Year
$7.98
$6.77
Revenue Next Year
$6.77
$6.06
P/E Ratio
★ $40.64
$161.75
Revenue Growth
4.78
★ 41.60
52 Week Low
$234.59
$154.50
52 Week High
$379.23
$277.40

Technical Indicators

Market Signals
Indicator
LHX
IQV
Relative Strength Index (RSI) 26.32 45.10
Support Level $234.59 $252.53
Resistance Level $269.50 $274.60
Average True Range (ATR) 4.72 7.46
MACD 0.63 -2.37
Stochastic Oscillator 11.27 12.46

Price Performance

Historical Comparison
LHX
IQV

About LHX L3Harris Technologies Inc.

In addition to its legacy software-defined radio franchise, L3Harris Technologies has, through a series of acquisitions, established franchises producing uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. It is also adept at refitting civilian aircraft for military use, provides military and commercial training services, and maintains the US Federal Aviation Administration's communication infrastructure.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: